Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TUCIDINOSTAT for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TUCIDINOSTAT was used for Lymphoma.

Most Reported Side Effects for TUCIDINOSTAT

Side Effect Reports % Deaths Hosp.
Myelosuppression 85 33.9% 4 24
Disease progression 37 14.7% 19 3
Anaemia 33 13.2% 5 4
Pneumonia 30 12.0% 13 5
Off label use 28 11.2% 7 10
Platelet count decreased 24 9.6% 3 11
Nausea 22 8.8% 5 3
White blood cell count decreased 21 8.4% 1 8
Drug ineffective 19 7.6% 8 2
Treatment failure 16 6.4% 12 4
Neutrophil count decreased 15 6.0% 0 4
Thrombocytopenia 15 6.0% 4 3
Febrile neutropenia 13 5.2% 2 0
Pyrexia 13 5.2% 1 5
Hypokalaemia 12 4.8% 1 4

Other Indications for TUCIDINOSTAT

Diffuse large b-cell lymphoma (63) Acute myeloid leukaemia (39) Peripheral t-cell lymphoma unspecified (17) Diffuse large b-cell lymphoma refractory (14) Chemotherapy (12) Angioimmunoblastic t-cell lymphoma (7) Plasma cell myeloma (7) T-cell lymphoma (6) Acute myeloid leukaemia refractory (5) Cutaneous t-cell lymphoma (5)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

TUCIDINOSTAT Full Profile All Lymphoma Drugs TUCIDINOSTAT Demographics TUCIDINOSTAT Timeline